Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014

ASH 2014: Expert discussion on the latest in CLL

Prof John Gribben and Prof Stephan Stilgenbauer
ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )
7 Dec 2014

Anti-CD38 antibody SAR may be new "blockbuster" treatment for aggressive multiple myeloma

Dr Thomas Martin, MD, University of California, San Francisco, USA
Anti-CD38 antibody SAR may be new "blockbuster" treatment for aggressive multiple myeloma ( Dr Thomas Martin, MD, University of California, San Francisco, USA )
7 Dec 2014

Investigational antibody demonstrates efficacy, safety for patients with aggressive multiple myeloma in phase I study

Dr Thomas Martin, MD, University of California, San Francisco, USA
Investigational antibody demonstrates efficacy, safety for patients with aggressive multiple myeloma in phase I study ( Dr Thomas Martin, MD, University of California, San Francisco, USA )
7 Dec 2014

Predicting the relapse of acute myeloid leukaemia with genetic screening

Dr Elaine Mardis - University of Washington, Washington, USA
Predicting the relapse of acute myeloid leukaemia with genetic screening ( Dr Elaine Mardis - University of Washington, Washington, USA )
2 Dec 2014

Choosing personalised treatment options based on molecular evidence

Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA
Choosing personalised treatment options based on molecular evidence ( Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA )
1 Dec 2014

ecancermedicalscience editor's choice for November 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for November 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
28 Nov 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion

Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo
New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion ( Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo )
24 Nov 2014

Early events found to trigger lung cancer twenty years before diagnosis

Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK
Early events found to trigger lung cancer twenty years before diagnosis ( Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK )
14 Nov 2014

Potential role of blood testing for microRNA profiles in paediatric cancers

Dr Matthew Murray - University of Cambridge, Cambridge, UK
Potential role of blood testing for microRNA profiles in paediatric cancers ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )
11 Nov 2014

Cancer genomics and pancreatic cancer

Prof Andrew Biankin - University of Glasgow, Glasgow, UK
Cancer genomics and pancreatic cancer ( Prof Andrew Biankin - University of Glasgow, Glasgow, UK )
11 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation